"Stanford Study: Ibogaine's Dramatic Impact on PTSD and Depression in Military Veterans"
A Stanford University study found that military veterans with traumatic brain injuries experienced "dramatic" and "life-changing" improvements in symptoms and cognitive functioning after receiving ibogaine treatment in Mexico, with significant reductions in PTSD, depression, and anxiety. The veterans' disability ratings dropped, and cognitive assessments showed improvements in concentration, memory, and impulsivity. The study suggests that ibogaine could be a powerful therapeutic for psychiatric symptoms related to TBI and combat exposure, prompting increased interest in psychedelic research and potential DEA production quota escalation.